Morgan Stanley’s Monogram Orthopaedics MGRM Stock Holding History

Morgan Stanley’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,207	Closed	-$54K	–	8370
2025 Q3	$54K	Buy	9,207 +5,010	+119%	+$26.8K	﹤0.01%	6370
2025 Q2	$12.1K	Sell	4,197 -10,674	-72%	-$28.8K	﹤0.01%	6797
2025 Q1	$43.7K	Buy	14,871 +105	+0.7%	+$278	﹤0.01%	6317
2024 Q4	$35K	Buy	14,766 +5,400	+58%	+$12.7K	﹤0.01%	6398
2024 Q3	$24.8K	Buy	9,366 +160	+2%	+$417	﹤0.01%	6439
2024 Q2	$19.8K	Buy	9,206 +302	+3%	+$662	﹤0.01%	6467
2024 Q1	$21.7K	Buy	8,904 +4,516	+103%	+$13.3K	﹤0.01%	6463
2023 Q4	$15.1K	Buy	4,388 +1,500	+52%	+$4.52K	﹤0.01%	6522
2023 Q3	$7.51K	Sell	2,888 -1,802	-38%	-$7.58K	﹤0.01%	6813
2023 Q2	$18.7K	Buy	+4,690	New	+$24.3K	﹤0.01%	6593

Morgan Stanley's MGRM Position: Q4 2025 in Review

Morgan Stanley sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 9,207 shares — an estimated $54K sold.

Morgan Stanley first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $54K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Morgan Stanley reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Morgan Stanley sold 9,207 Monogram Orthopaedics shares in Q4 2025, an estimated $54K.
Morgan Stanley first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
Morgan Stanley's Monogram Orthopaedics position peaked at $54K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.